• Non ci sono risultati.

non-small cell - stage III or IV

N/A
N/A
Protected

Academic year: 2021

Condividi "non-small cell - stage III or IV"

Copied!
1
0
0

Testo completo

(1)

S1 Text Inclusion and exclusion criteria ACTION study

Inclusion Criteria Exclusion Criteria

Histologically confirmed diagnosis of:

 Lung cancer:

- small cell - extensive disease/ Stage III or IV*

- non-small cell - stage III or IV*

 Colorectal cancer: Stage IV ormetachronous metastases*

*according to 7th edition of TNM classification and staging system

Written informed consent to participate WHO performance status of 0-3.

 Age < 18 years

 Unable to provide informed consent

 Unable to complete questionnaire in country’s language

 Less than 3 months anticipated life expectancy

 Taking part in a research study that is evaluating palliative care services or communication strategies.

Riferimenti

Documenti correlati

This difference between West Flemish and German follows, if we assume, as I have argued in chapter 3, that in West Flemish only finite verbs can move to the head of AspP.. Else

In this regard, it has been pointed out that a good mix be- tween weak and strong ties is needed to keep opportunism under control and to miti- gate altruism, thereby giving rise to

Punta Helbronner (drawing by author). From the upper station it is easy to reach by a tunnel and a system of cages and lifts to the Rifugio Torino shelter, which is a resting place

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III studyR.

Finally, with regard to the HPCSs admitted within the Best Practice Panel, we examined main process measures, and particularly: the percentage of assisted cancer and pediatric

As a consequence of the increased concentration of phenolic compounds in the in vitro digestion extracts, RSA of fortified yogurts after in vitro digestion was higher for both

Indeed, two groups have recently computed the fully differential decay width of the Higgs boson into bottom quarks up to Oðα 2 s Þ for the massless case, and merged this computation

It remains to be clarified whether APP Ala713Thr mutation is linked to AD without in vivo evidence of A␤ biomarkers or more likely to other pathol- ogy as FTD, and the debate